News

We are excited to announce that our abstract, titled “Performance characteristics of a new, fully automated planar microarray immunoassay for the detection of autoantibodies against Centromere Protein B and correlations with autoimmune disease diagnosis” will be presented at the 2023

Quotient and FAS Diagnostic Group, Inc. have signed a distribution agreement, which will enable FAS Diagnostic Group, Inc. to distribute Alba by Quotient® and MosaiQ® in the Philippines, Southeast Asia. The distribution agreement takes effect immediately. This strategic partnership reaffirms Quotient’s

We are excited to announce that we are in Bangkok, Thailand, from 16-18 August for Medlab Asia. Visit us in hall 6 of the IMPACT Exhibition Center, booth number B10 where our team of experts will be delighted to welcome

We are pleased to announce the next chapter of our exciting journey as a disruptive innovator in clinical diagnostics: Quotient is becoming AliveDx.   AliveDx is more than a name, it is a call to action. AliveDx brings urgency to

We are excited to announce that our abstract has been accepted by the 2023 AACC Annual Scientific Meeting & Clinical Expo in Anaheim, California. To read a copy of the abstract click here. A performance evaluation study conducted at Hôpital

We are pleased to announce that we have successfully passed the annual ISO 14001 Surveillance Audit for our Eysins site in Switzerland. The ISO 14001 is an internationally recognized standard for environmental management systems (EMS). This certification reaffirms the Eysins

Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia. This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will

We are pleased to announce that Alba by Quotient™ continues to grow in Europe and is now available in the Netherlands and Sweden in addition to the following geographies: Austria France Germany Greece Hungary Italy Luxembourg Netherlands Poland Romania Slovakia

We are excited to share that our abstract titled: “Performance of a solid-phase photometric single use immunoassay microarray prototype in the detection of IgG antibodies against Centromere Protein B (CENP-B) in human serum” has been accepted by the European Alliance

In May 2022, the EU implemented the new in-vitro medical devices Regulation (IVDR) to ensure the safety and performance of in-vitro diagnostic medical devices. This new regulation became mandatory for all manufacturers placing IVD products on the EU market. We